Termination of Pregnancy With Mifepristone and Misoprostol Versus Sulprostone
1 other identifier
observational
N/A
1 country
1
Brief Summary
The purpose of this study is to determine which medical treatment is the most effective to terminate a pregnancy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 13, 2005
CompletedFirst Posted
Study publicly available on registry
September 21, 2005
CompletedOctober 30, 2007
September 1, 2005
September 13, 2005
October 29, 2007
Conditions
Keywords
Interventions
Eligibility Criteria
You may qualify if:
- Pregnant women by whom a termination of pregnancy is desired.
You may not qualify if:
- Women with liver/kidney disease
- Women on long-term use of corticosteroids (\> 6 months)
- Cardiovascular problems
- Therapy-resistant diabetic women
- Therapy-resistant asthma/bronchitis
- Thalassemia
- Ulcerative colitis
- Peptic ulcer disease
- Glaucoma
- Porphyria
- Allergic reaction to prostaglandin or mifepristone
- Women with a prior caesarian section or women with contractions at the start of the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Atrium Medisch Centrum
Heerlen, Limburg, Netherlands
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
F Roumen, Dr.
Atrium Medisch Centrum, Heerlen
Central Study Contacts
Study Design
- Study Type
- observational
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
September 13, 2005
First Posted
September 21, 2005
Last Updated
October 30, 2007
Record last verified: 2005-09